All studies
RecruitingNAINTERVENTIONAL

J-Valve Transfemoral Pivotal Study

This research is looking at a new way to replace a leaky aortic valve, called the J-Valve Transfemoral (TF) System, for patients who can't have standard open-heart surgery. It's for people experiencing severe leaking of their aortic valve (a condition called aortic regurgitation or AR) that is causing symptoms like breathlessness or tiredness. Doctors want to see if this new procedure is both safe and works well to improve heart health. A special part of the study will also use detailed heart scans to understand how the heart changes after the new valve is put in and how this affects people's quality of life, looking at differences between men and women too.

At a glance

Status
Recruiting
Phase
NA
Sponsor
JC Medical, Inc., an affiliate of Edwards Lifesciences LLC
Enrolment target
194
Start
17 Oct 2024
Estimated completion
01 Feb 2032

What is this study about?

This study is investigating a new type of heart valve replacement called the J-Valve Transfemoral (TF) System. It's designed for people who have a significant problem with their aortic valve – specifically, severe aortic regurgitation (AR). This means the aortic valve, which controls blood flow out of your heart, isn't closing properly, causing blood to leak back into the heart. If this leaking is severe and causes symptoms, it can put a strain on your heart.

Traditionally, a faulty aortic valve is replaced with open-heart surgery. However, for some individuals, open-heart surgery carries too many risks due to their other health conditions. This study is focusing on these patients, offering a less invasive way to replace the valve, hoping to provide a safer option for them. The main goal is to find out if the J-Valve TF System is both safe to use and effective in treating severe aortic regurgitation.

Beyond simply replacing the valve, researchers also want to understand the bigger picture. They will use detailed heart scans, called Cardiac Magnetic Resonance (CMR), to see if replacing the leaky valve helps the heart recover and improve its pumping ability. They'll also explore how these heart changes impact patients' overall well-being and quality of life, and if there are any differences in how men and women respond to the treatment.

Key takeaways

  • It's a new, less invasive way to replace a leaky aortic valve.
  • Specifically for patients too risky for traditional open-heart surgery.
  • Aims to check if the new valve is safe and works well.
  • Includes detailed heart scans to understand heart recovery.
  • Requires follow-up appointments for five years.

Who may be eligible?

This study is looking for adults aged 18 and over who have been diagnosed with severe leaking of their aortic valve (aortic regurgitation or AR). You would need to be experiencing symptoms such as breathlessness or fatigue due to your heart condition. Very importantly, a team of heart specialists must have decided that open-heart surgery to replace your valve would be too risky for you.

Your heart valve problem needs to be clearly identified as severe AR through detailed scans. Also, your heart's structure must be suitable for the J-Valve TF System to be put in safely. You'd also need to be able to give your informed consent, meaning you understand the study and agree to take part, including attending all follow-up appointments.

There are also reasons why you might not be able to join the study. For example, if you've already had an artificial aortic valve fitted, or if you have other serious heart valve problems that are equally severe. Certain other serious health conditions, like active infections, severe kidney or liver disease, or certain blood disorders, would also prevent you from participating in this study.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. Do I have a severely leaky aortic valve?
  2. Am I experiencing symptoms like breathlessness or tiredness?
  3. Has my heart care team said open-heart surgery is too risky for me?
  4. Am I 18 years old or older?
  5. Do I agree to attend all follow-up appointments for five years?
Answer every question to see your result.

What does participation involve?

If you join this study, you will receive the J-Valve TF System implant. Before the procedure, you'll undergo thorough health checks and scans to ensure it's suitable for you. After the procedure, you will have regular follow-up appointments and various assessments for up to five years. These appointments will involve checking your general health, heart function, and how you are feeling. You will also need to take specific medicines, such as blood thinners, as prescribed by the study doctors. The total duration of your participation will be five years from the date of your implant procedure.

Potential risks and benefits

Potential benefits of participating include receiving a new, less invasive treatment for your severe aortic valve leak, which might improve your symptoms and heart function, especially if open-heart surgery is too risky for you. However, as with any medical procedure, there are potential risks, including those associated with heart procedures and anaesthesia. The study aims to carefully monitor and manage these. Your safety and well-being are paramount, and you have the right to withdraw from the study at any time, for any reason, without it affecting your medical care.

Locations (40)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.
  • HonorHealth Research & Innovation Institute
    Verified postcode
    Scottsdale, United States· Recruiting
  • Scripps Memorial Hospital La Jolla
    Verified postcode
    La Jolla, United States· Recruiting
  • Cedars Sinai
    Verified postcode
    Los Angeles, United States· Recruiting
  • Stanford University Medical Center
    Verified postcode
    Palo Alto, United States· Recruiting
  • Bay Area Structural Heart at Sutter Health
    Verified postcode
    San Francisco, United States· Recruiting
  • University of California San Francisco
    Verified postcode
    San Francisco, United States· Recruiting
  • UC Health Northern Colorado (Medical Center of the Rockies)
    Verified postcode
    Loveland, United States· Recruiting
  • Washington Hospital Center DC
    Verified postcode
    Washington D.C., United States· Recruiting
  • NCH Rooney Heart Institute
    Verified postcode
    Naples, United States· Recruiting
  • Emory University Atlanta
    Verified postcode
    Atlanta, United States· Recruiting
  • Piedmont
    Verified postcode
    Atlanta, United States· Recruiting
  • Northwestern University Chicago
    Verified postcode
    Chicago, United States· Recruiting

Common questions

What is aortic regurgitation?

Aortic regurgitation means your heart's aortic valve isn't closing tightly, causing blood to leak backward into your heart. This can make your heart work harder.

What is the J-Valve TF System?

It's a new heart valve replacement designed to be put in through a small cut, rather than open-heart surgery. TF stands for Transfemoral, meaning it's inserted via a blood vessel in the leg.

Why is this study important?

It offers a potential new treatment option for people with severe leaky aortic valves who are considered too sick for traditional open-heart surgery, aiming to improve their health and quality of life.

How long will I be involved in the study?

If you participate, you will be followed up by the study team for five years after receiving the J-Valve TF System.

Will I have to take new medications?

Yes, you will likely need to take certain medications, such as blood thinners, as recommended by the study doctors after the procedure.

How to find out more

Sheri L Halverson, MPH

Always speak to your GP or specialist before deciding to take part in a study.

Interested in taking part?

Register your interest

Share your details and the research team for "J-Valve Transfemoral Pivotal Study…" will contact you if you may be eligible. Always speak to your GP before agreeing to take part.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.